NanoMosaic Secures FDA AMT Designation to Accelerate Advanced Gene Therapy Analytics NanoMosaic has earned the U.S. Food and Drug Administration’s (FDA) Advanced Manufacturing Technology (AMT) designation, signaling a pivotal step for developers and manufacturers leveraging the company’s analytics platform for gene therapies. The designation aims to streamline regulatory engagement, improve product quality, and expedite the…